Home » Optovue Receives FDA 510(k) Clearance of the RTVue XR FD-OCT
Optovue Receives FDA 510(k) Clearance of the RTVue XR FD-OCT
Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minn., announced that it has secured market clearance for its diagnostic device.
MedCity News
MedCity News
Upcoming Events
-
07May
-
14May
-
30May